| Product Code: ETC066680 | Publication Date: Aug 2021 | Updated Date: Aug 2025 | Product Type: Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Infectious Disease Point-of-care Testing Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Infectious Disease Point-of-care Testing Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Infectious Disease Point-of-care Testing Market - Industry Life Cycle |
3.4 United States (US) Infectious Disease Point-of-care Testing Market - Porter's Five Forces |
3.5 United States (US) Infectious Disease Point-of-care Testing Market Revenues & Volume Share, By Applications, 2021 & 2031F |
3.6 United States (US) Infectious Disease Point-of-care Testing Market Revenues & Volume Share, By Technologies, 2021 & 2031F |
3.7 United States (US) Infectious Disease Point-of-care Testing Market Revenues & Volume Share, By End-users, 2021 & 2031F |
4 United States (US) Infectious Disease Point-of-care Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in the United States |
4.2.2 Growing demand for rapid and accurate diagnostic tests |
4.2.3 Technological advancements in point-of-care testing leading to improved efficiency and accuracy |
4.3 Market Restraints |
4.3.1 Regulatory challenges and approvals for new point-of-care testing devices |
4.3.2 Limited reimbursement policies for point-of-care testing |
4.3.3 Competition from traditional laboratory testing methods |
5 United States (US) Infectious Disease Point-of-care Testing Market Trends |
6 United States (US) Infectious Disease Point-of-care Testing Market, By Types |
6.1 United States (US) Infectious Disease Point-of-care Testing Market, By Applications |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Infectious Disease Point-of-care Testing Market Revenues & Volume, By Applications, 2018 - 2027F |
6.1.3 United States (US) Infectious Disease Point-of-care Testing Market Revenues & Volume, By Tropical Disease, 2018 - 2027F |
6.1.4 United States (US) Infectious Disease Point-of-care Testing Market Revenues & Volume, By Liver Disease, 2018 - 2027F |
6.1.5 United States (US) Infectious Disease Point-of-care Testing Market Revenues & Volume, By Respiratory Disease, 2018 - 2027F |
6.1.6 United States (US) Infectious Disease Point-of-care Testing Market Revenues & Volume, By Sexual Disorders, 2018 - 2027F |
6.1.7 United States (US) Infectious Disease Point-of-care Testing Market Revenues & Volume, By Others, 2018 - 2027F |
6.2 United States (US) Infectious Disease Point-of-care Testing Market, By Technologies |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Infectious Disease Point-of-care Testing Market Revenues & Volume, By Lateral Flow, 2018 - 2027F |
6.2.3 United States (US) Infectious Disease Point-of-care Testing Market Revenues & Volume, By Flow-through, 2018 - 2027F |
6.2.4 United States (US) Infectious Disease Point-of-care Testing Market Revenues & Volume, By Agglutination Assays, 2018 - 2027F |
6.2.5 United States (US) Infectious Disease Point-of-care Testing Market Revenues & Volume, By Solid Phase, 2018 - 2027F |
6.3 United States (US) Infectious Disease Point-of-care Testing Market, By End-users |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Infectious Disease Point-of-care Testing Market Revenues & Volume, By Diagnostic Laboratories, 2018 - 2027F |
6.3.3 United States (US) Infectious Disease Point-of-care Testing Market Revenues & Volume, By Hospitals, 2018 - 2027F |
6.3.4 United States (US) Infectious Disease Point-of-care Testing Market Revenues & Volume, By Home-care Settings, 2018 - 2027F |
6.3.5 United States (US) Infectious Disease Point-of-care Testing Market Revenues & Volume, By Others, 2018 - 2027F |
7 United States (US) Infectious Disease Point-of-care Testing Market Import-Export Trade Statistics |
7.1 United States (US) Infectious Disease Point-of-care Testing Market Export to Major Countries |
7.2 United States (US) Infectious Disease Point-of-care Testing Market Imports from Major Countries |
8 United States (US) Infectious Disease Point-of-care Testing Market Key Performance Indicators |
8.1 Average turnaround time for test results |
8.2 Adoption rate of point-of-care testing by healthcare providers |
8.3 Frequency of new product launches and innovations in the market |
9 United States (US) Infectious Disease Point-of-care Testing Market - Opportunity Assessment |
9.1 United States (US) Infectious Disease Point-of-care Testing Market Opportunity Assessment, By Applications, 2021 & 2031F |
9.2 United States (US) Infectious Disease Point-of-care Testing Market Opportunity Assessment, By Technologies, 2021 & 2031F |
9.3 United States (US) Infectious Disease Point-of-care Testing Market Opportunity Assessment, By End-users, 2021 & 2031F |
10 United States (US) Infectious Disease Point-of-care Testing Market - Competitive Landscape |
10.1 United States (US) Infectious Disease Point-of-care Testing Market Revenue Share, By Companies, 2021 |
10.2 United States (US) Infectious Disease Point-of-care Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here